Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| REKOVELLE | FERRING INC | Actual shortage | 36MCG | Updated Report | 2020-12-01 | 101018 |
| REKOVELLE | FERRING INC | Actual shortage | 12MCG | Updated Report | 2020-12-01 | 101024 |
| REKOVELLE | FERRING INC | Actual shortage | 72MCG | Updated Report | 2020-12-01 | 101003 |
| DURATOCIN | FERRING INC | Actual shortage | 100MCG | Updated Report | 2020-12-01 | 129238 |
| ARAVA 20 MG | SANOFI-AVENTIS CANADA INC | Actual shortage | 20MG | Updated Report | 2020-12-01 | 128414 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | PURDUE PHARMA | Anticipated shortage | 18MG | New Report | 2020-12-01 | 129224 |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | PURDUE PHARMA | Resolved | 18MG | Updated Report | 2020-12-01 | 127123 |
| DILAUDID | PURDUE PHARMA | Actual shortage | 8MG | Updated Report | 2020-12-01 | 127120 |
| APO-TADALAFIL | APOTEX INC | Actual shortage | 5MG | Updated Report | 2020-12-01 | 127376 |
| APO-RAMIPRIL | APOTEX INC | Actual shortage | 2.5MG | Updated Report | 2020-12-01 | 127754 |
| APO-LISINOPRIL TABLET 5 MG | APOTEX INC | Actual shortage | 5MG | Updated Report | 2020-12-01 | 126292 |
| APO-LISINOPRIL TABLET 20 MG | APOTEX INC | Actual shortage | 20MG | Updated Report | 2020-12-01 | 128606 |
| APO IBUPROFEN TAB 400MG | APOTEX INC | Actual shortage | 400MG | Updated Report | 2020-12-01 | 126283 |
| APO IBUPROFEN TAB 400MG | APOTEX INC | Actual shortage | 400MG | Updated Report | 2020-12-01 | 77890 |
| ISOPTIN SR | BGP PHARMA ULC | Actual shortage | 120MG | Updated Report | 2020-12-01 | 118074 |
| TEVETEN | BGP PHARMA ULC | Anticipated shortage | 400MG | New Report | 2020-12-01 | 129203 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 150MCG | Updated Report | 2020-12-01 | 124241 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 100MCG | Updated Report | 2020-12-01 | 126687 |
| SYNTHROID | BGP PHARMA ULC | Actual shortage | 88MCG | New Report | 2020-12-01 | 129196 |
| SYNTHROID | BGP PHARMA ULC | Anticipated shortage | 25MCG | New Report | 2020-12-01 | 129193 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | Discontinued | 20MG | Updated Report | 2020-12-01 | 68392 |
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | Discontinued | 40MG | Updated Report | 2020-12-01 | 68395 |
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | To be discontinued | 40MG | New Report | 2020-11-30 | 129134 |
| PRAVACHOL | BRISTOL-MYERS SQUIBB CANADA | To be discontinued | 20MG | New Report | 2020-11-30 | 129131 |
| AVANDIA | GLAXOSMITHKLINE INC | Discontinued | 4MG | Updated Report | 2020-11-27 | 113314 |
